Open
FAST-Trac Award
Funding for translational Angelman syndrome research
Record updated
- Funding available
- $ 150,000
- Up to 5% of project cost
- Deadline
- Open continuously
- Location
- Canada
Overview
FAST-TRAC Award supports research to advance potential Angelman syndrome treatments, with up to $150,000 per year for one-year or two-year grants to nonprofit organizations and, in rare cases, contract research organizations or industry scientific teams. Eligible work includes gene modification, disease modification, symptom-alleviating therapeutics, and high-throughput drug screening platforms.
At a glance
Funding available
- Maximum funding
- $150,000
- Maximum share of project costs
- 5%
- Develop a new program or service
- Enhance an existing program
- Conduct research and development activities
- Conduct research or evaluation activities
Eligible candidates
- Location
- Canada
- Eligible Industries
- All industries
- Annual revenue
- All revenue ranges
- Organisation size
- All organization sizes
- Audience
- All groups
- Legal structures
- Non-profit
Non-profit candidates
- Sector of operation
- Research
- Target groups
- People with disabilities, Nonprofits / charities, Academia / students
- Revenue structures
- 100% donations / grants
- Scope
- National, International
Start applying for this program
Take a practical assessment to gain a clear understanding of how well this program aligns with your specific needs and long-term goals.
Availability timeline
2026
Periods: 1
Eligibility
Who is eligible?
- Nonprofit organizations.
- Contract research organizations or industry scientific teams in rare circumstances.
- Individuals with training and experience at least equal to the PhD or MD level.
Who is not eligible
- Grant applications with essentially the same research focus from the same applicant organization.
- Derivative or multiple applications that aim to create a single product, process, or service with minor modifications.
Eligible expenses
- Reagents and materials, including cell lines and animal model lines.
- Specialized services such as sequencing, proteomics, metabolomics, and manufacturing.
- Specialized equipment or software needed for the project.
- Personnel costs, including salaries and fringe benefits.
- Travel support for the annual FAST scientific symposium.
Ineligible Costs and Activities
- Indirect costs on tuition, equipment, software, or software licenses.
- Travel costs beyond the included symposium stipend, unless not used and returned.
Activities funded
- Creation or enhancement of potential treatments for Angelman syndrome.
- Gene modification, disease modification, and symptom-alleviating therapeutics.
- Diverse platforms and tools for high-throughput drug screening.
How to apply
- All grant applications are considered on a rolling basis.
- Email science@cureangelman.org for more information.
- Provide a letter of intent if you are considering applying for a grant.
Documents Needed
- Letter of intent.
- FAST Year-End or Final Progress Report.
- Financial report.
- Official request letter.
Selection criteria
- Scientific merit.
- Innovation.
- Translational impact and alignment with FAST’s mission.
- Experimental design, methods, rationale, budget, and feasibility.
- NIH standard scoring guidelines, with emphasis on scientific rigor and relevance to FAST’s mission.
Processing and Agreement
- Applications are reviewed through scientific peer review by the Scientific Advisory Board, and consultants may be recruited if needed.
- Applications are scored using NIH standard guidelines and reviewed for scientific merit, innovation, translational impact, alignment with FAST's mission, experimental design, methods, rationale, budget, and feasibility.
- Applicants may need to respond to Scientific Advisory Board questions or recommendations before final review.
- The Scientific Panel compiles recommendations, and final approval is required by the FAST Board of Directors before funding occurs.
- FAST aims to provide a funding response within six weeks of receiving the grant submission; progress reports are expected every 6 months, end-of-project reports are due within 8 weeks of the end of the grant period, and grant renewals, no-cost extensions, and carry-forward requests must be submitted at least 30 days before the relevant deadline.
Additional information
- Human subjects studied in the course of research supported by FAST must be volunteers.
- Institutional review board approval is required before dispersal of funds for any award using human subjects.
- Written certification is required when animals are used, confirming proper treatment, care, and humane conditions.
- Institutional Animal Care and Use Committee approval is required before starting any animal work on a FAST grant.
Contacts
Official sources
Frequently Asked Questions about the FAST-Trac Award Program
What is the FAST-Trac Award?
FAST-TRAC Award supports research to advance potential Angelman syndrome treatments, with up to $150,000 per year for one-year or two-year grants to nonprofit organizations and, in rare cases, contract research organizations or industry scientific teams. Eligible work includes gene modification, disease modification, symptom-alleviating therapeutics, and high-throughput drug screening platforms.
How much funding can be received?
FAST-Trac Award Funds up to 5% of admissible expenses, capped at $150,000 per project.
What is the deadline to apply?
The program is accepting continuous intake
Who is eligible for the FAST-Trac Award program?
To be eligible for the FAST-Trac Award program, you must:
Applicant institutions are generally recognized as nonprofit organizations.
In rare circumstances, contract research organizations or industry scientific teams may receive funding.
Individuals must have training and experience at least equal to the PhD or MD level.
What expenses are eligible under FAST-Trac Award?
Reagents and materials, including cell lines and animal model lines.
Specialized services such as sequencing, proteomics, metabolomics, and manufacturing.
Specialized equipment or software needed for the project.
Personnel costs, including salaries and fringe benefits.
Travel support for the annual FAST scientific symposium.
Who can I contact for more information about the FAST-Trac Award?
You can contact Foundation for Angelman Syndrome Therapeutics (FAST) by email at grants@cureangelman.org or by phone at 630-852-3278.
Where is the FAST-Trac Award available?
The FAST-Trac Award program is available across Canada.